Bausch + Lomb Corporation (BLCO)

17.41 +0.36 (+2.11%) At close: 04:00PM EDT

Bausch + Lomb Corporation

520 Applewood Crescent
Vaughan, ON L4K 4B4
Canada
905 695 7700
https://www.bausch.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 12,800

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Joseph C. Papa	CEO & Director	4.08M	N/A	1956
Mr. Osama A. Eldessouky	Exec. VP & CFO	1.37M	N/A	1972
Ms. Christina M. Ackermann	Exec. VP, Gen. Counsel & Pres of Ophthalmic Pharmaceuticals	1.63M	2.06M	1965
Mr. Joseph F. Gordon	Pres of Global Consumer, Surgical & Vision Care	1.36M	N/A	1965
Ms. Kelly Webber	Exec. VP & Chief HR Officer	N/A	N/A	N/A
Dr. Yehia Hashad M.D.	Exec. VP of R&D and Chief Medical officer	N/A	N/A	1967
Mr. Louis W. Yu	Exec. VP & Chief Quality Officer	N/A	N/A	1950
Mr. Dennis Asharin	Exec. VP and Chief Global Manufacturing & Supply Chain Officer	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Corporate governance

Bausch + Lomb Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.